Performing Peptide Bioanalysis Using High Resolution Mass Spectrometry with Target Enhancement MRM Acquisition

Importance of the topic

The emergence of biotherapeutics has driven a growing need for reliable peptide and protein quantitation in drug discovery and development. High-resolution mass spectrometry (HRMS) platforms now offer the ability to perform both qualitative characterization and targeted quantitation on the same system, improving throughput, selectivity, and sensitivity when analyzing complex biological matrices.

Objectives and study overview

This study demonstrates the use of Time-of-Flight Multiple Reaction Monitoring (Tof-MRM) acquisition on the ionKey/Xevo G2-XS QTof system for quantitative bioanalysis of a commercially available peptide standard (MSQC1). The goal was to establish a streamlined workflow from peptide mapping to precise quantitation with excellent linearity and low detection limits.

Methodology

A mixture of eight surrogate peptides, each labeled with stable isotopes, was serially diluted from 1:16 to 1:4096. Peptide transitions were evaluated in a scouting experiment comparing three precursor-to-fragment channels and a tuneless precursor-to-precursor channel. Overlaid extracted ion chromatograms identified the most sensitive transitions for quantitation. A final Tof-MRM method with optimized collision energy, cone voltage, and narrow retention time windows was created and applied.

Used instrumentation

• ionKey/MS microfluidic separation device (HSS T3, 150 µm × 50 mm)
• Xevo G2-XS QTof mass spectrometer in Tof-MRM mode
• MassLynx software for method setup and data acquisition
• TargetLynx for quantitative data processing

Main results and discussion

The tuneless precursor-to-precursor transition delivered the highest signal intensity. Quantitation of selected peptides across dilutions yielded linear responses (R2 ≥ 0.99) from 1:64 to 1:4096 for light peptides and comparable linearity for heavy-labeled analogues without detector saturation. Signal-to-noise ratios remained high at the lowest concentrations, confirming excellent sensitivity.

Benefits and practical applications

• A unified HRMS platform enables both peptide mapping and quantitation without instrument changes.
• Tof-MRM with target enhancement simplifies targeted assays while retaining high resolution.
• Microfluidic ionKey separation boosts selectivity and sensitivity, especially at low flow rates.

Future trends and possibilities

Advances in HRMS acquisition modes will further bridge the gap between qualitative and quantitative workflows. Integration with automated sample preparation and data-driven method optimization using artificial intelligence can accelerate assay development. Expanded use of targeted HRMS for intact protein analysis and multiplexed immunoassays is anticipated.

Conclusion

Targeted HRMS acquisition using Tof-MRM on the ionKey/Xevo G2-XS offers a robust, high-throughput solution for peptide bioanalysis. The demonstrated linear range, sensitivity, and streamlined workflow underscore its suitability for both research and regulated bioanalysis environments.